These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2401562

  • 1. Characterization of Leishmania major antigen-liposomes that protect BALB/c mice against cutaneous leishmaniasis.
    Kahl LP, Lelchuk R, Scott CA, Beesley J.
    Infect Immun; 1990 Oct; 58(10):3233-41. PubMed ID: 2401562
    [Abstract] [Full Text] [Related]

  • 2. Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization.
    Kahl LP, Scott CA, Lelchuk R, Gregoriadis G, Liew FY.
    J Immunol; 1989 Jun 15; 142(12):4441-9. PubMed ID: 2786033
    [Abstract] [Full Text] [Related]

  • 3. The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63).
    Badiee A, Jaafari MR, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F.
    Exp Parasitol; 2009 Apr 15; 121(4):362-9. PubMed ID: 19211022
    [Abstract] [Full Text] [Related]

  • 4. Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice.
    Afrin F, Rajesh R, Anam K, Gopinath M, Pal S, Ali N.
    Infect Immun; 2002 Dec 15; 70(12):6697-706. PubMed ID: 12438344
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major.
    Yang DM, Rogers MV, Liew FY.
    Immunology; 1991 Jan 15; 72(1):3-9. PubMed ID: 1997399
    [Abstract] [Full Text] [Related]

  • 9. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P, Pearce E, Natovitz P, Sher A.
    J Immunol; 1987 Jul 01; 139(1):221-7. PubMed ID: 3495599
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of immune response and protection in BALB/c mice immunized with liposomal recombinant major surface glycoprotein of Leishmania (rgp63): the role of bilayer composition.
    Badiee A, Jaafari MR, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F.
    Colloids Surf B Biointerfaces; 2009 Nov 01; 74(1):37-44. PubMed ID: 19615870
    [Abstract] [Full Text] [Related]

  • 11. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.
    Bogdan C, Schröppel K, Lohoff M, Röllinghoff M, Solbach W.
    Eur J Immunol; 1990 Dec 01; 20(12):2533-40. PubMed ID: 1980108
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome.
    Jaafari MR, Badiee A, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F.
    Vaccine; 2007 Aug 10; 25(32):6107-17. PubMed ID: 17629372
    [Abstract] [Full Text] [Related]

  • 14. Transcutaneous immunization using SLA or rLACK skews the immune response towards a Th1 profile but fails to protect BALB/c mice against a Leishmania major challenge.
    Lakhal-Naouar I, Koles N, Rao M, Morrison EB, Childs JM, Alving CR, Aronson NE.
    Vaccine; 2019 Jan 14; 37(3):516-523. PubMed ID: 30528328
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility to murine cutaneous leishmaniasis correlates with the capacity to generate interleukin 3 in response to leishmania antigen in vitro.
    Lelchuk R, Graveley R, Liew FY.
    Cell Immunol; 1988 Jan 14; 111(1):66-76. PubMed ID: 3257416
    [Abstract] [Full Text] [Related]

  • 16. Comparison of liposome based antigen delivery systems for protection against Leishmania donovani.
    Bhowmick S, Mazumdar T, Sinha R, Ali N.
    J Control Release; 2010 Jan 25; 141(2):199-207. PubMed ID: 19818373
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis.
    Eskandari F, Talesh GA, Parooie M, Jaafari MR, Khamesipour A, Saberi Z, Abbasi A, Badiee A.
    Exp Parasitol; 2014 Nov 25; 146():78-86. PubMed ID: 25246326
    [Abstract] [Full Text] [Related]

  • 20. Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA).
    Firouzmand H, Badiee A, Khamesipour A, Heravi Shargh V, Alavizadeh SH, Abbasi A, Jaafari MR.
    Acta Trop; 2013 Dec 25; 128(3):528-35. PubMed ID: 23916506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.